Early investigational agents for the treatment of benign prostatic hyperplasia’-Reference-Cited by-同舟云学术

Early investigational agents for the treatment of benign prostatic hyperplasia’

Published:2024-03-04 Issue:4 Volume:33 Page:359-370
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Katsimperis Stamatios¹,Kapriniotis Konstantinos²,Manolitsis Ioannis¹,Bellos Themistoklis¹,Angelopoulos Panagiotis¹,Juliebø-Jones Patrick³⁴,Somani Bhaskar⁵,Skolarikos Andreas¹,Tzelves Lazaros¹²

Affiliation:

1. 2nd University Department of Urology, Sismanoglio Hospital, National and Kapodistrian University of Athens, Athens, Greece

2. Department of Urology, University College of London Hospitals (UCLH), London, UK

3. Department of Urology, Haukeland University Hospital, Bergen, Norway

4. Department of Clinical Medicine, University of Bergen, Bergen, Norway

5. Department of Urology, University Hospital Southampton, Southampton, UK

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2024.2326023

Reference121 articles.

1. Saw palmetto for benign prostatic hyperplasia: just how effective is it?

2. Pathophysiology of lower urinary tract symptoms in the aging male population;Lepor H.;Rev Urol,2005

3. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men

4. The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study

5. Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment—the QUALIPROST study